Profil bibliographique

Antje Blank

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

118Publications signalées

3101Citations signalées

3Affiliations récentes

Institutions déclarées

Heidelberg University University Hospital Heidelberg German Center for Infection Research

Domaines associés

Hepatitis B Virus StudiesHepatitis C virus researchLiver Disease Diagnosis and TreatmentPharmacogenetics and Drug MetabolismGlobal Maternal and Child Health

Publications récentes

Accès ouvert 2026 articleOpenAlex

How to Optimize Healthy Volunteer Screening and Enrolment in Clinical Trials: A Qualitative and Quantitative Approach to Evaluate Processes and Healthy Volunteers' Perceptions

Evelyn Krohmer, Manuela König, Cathrin J. Vogt, Marina Streckebein et autres

0 citationsClinical Pharmacology & Therapeutics

Accès ouvert 2026 articleOpenAlex

MCL‐1 inhibition triggers a largely reversible cardiac stress signature in a humanised mouse model

Markus Heckmann, Zsanett Papdi, Nils J. Strauch, Daniel Finke et autres

0 citationsBritish Journal of Pharmacology

Accès ouvert 2026 articleOpenAlex

Effects of bulevirtide on atherosclerosis in an ApoE-deficient mouse model

Jonas Rusnak, Victoria Delcheva, Dirk Theile, Antje Blank et autres

0 citationsPLoS ONE

Accès ouvert 2026 articleOpenAlex

Interpretation of Pharmacometabolomics Results: Fingerprint of Drug Exposure or Confounder Effects? Insights from a Urinary Metabolomics Study with Voriconazole in Healthy Participants

Kristine Chobanyan-Jürgens, Amin Muhareb, Moritz Niesert, Camilo Scherkl et autres

0 citationsInternational Journal of Molecular Sciences

Accès ouvert 2026 articleOpenAlex

144 Weeks of bulevirtide monotherapy for chronic hepatitis D: Final and post-treatment results from a phase III randomized trial

Heiner Wedemeyer, Soo Aleman, Antje Blank, Pietro Andreone et autres

7 citationsJournal of Hepatology

Accès ouvert 2026 articleOpenAlex

A UPLC-MS/MS assay for the quantification of the novel viral helicase-primase drug candidate adibelivir (IM-250) in human specimen

Cindy Bay, Mariano Bergamino, Max Sauter, David Czock et autres

1 citationJournal of Chromatography B

2025 conference-abstractOpenAlex

P176 Predictors of undetectable hepatitis delta virus RNA at 48 weeks after end of treatment with bulevirtide monotherapy in the MYR301 study

Soo Aleman, Maurizia Rossana Brunetto, Antje Blank, Pietro Andreoné et autres

1 citation

2025 conference-abstractOpenAlex

P158 Final results of MYR301: a randomised phase 3 study evaluating the efficacy and safety of up to 144 weeks of bulevirtide monotherapy for chronic hepatitis delta and 96 weeks of posttreatment follow-up

Heiner Wedemeyer, Soo Aleman, Antje Blank, Pietro Andreoné et autres

0 citations

2025 conference-paperOpenAlex

Final results of MYR301: a randomised phase 3 study evaluating the efficacy and safety of up to 144 weeks of bulevirtide monotherapy for chronic hepatitis Delta and 96 weeks of posttreatment follow-up

H. Wedemeyer, Soo Aleman, Antje Blank, Pietro Andreoné et autres

1 citationZeitschrift für Gastroenterologie

2025 conference-paperOpenAlex

Predictors of undetectable hepatitis delta virus RNA at 48 weeks after end of treatment with bulevirtide monotherapy in the MYR301 study

Soo Aleman, Maurizia Brunetto, Antje Blank, Pietro Andreoné et autres

1 citationZeitschrift für Gastroenterologie

2025 conference-abstractOpenAlex

LBO-004 Final results of MYR301: a randomised phase 3 study evaluating the efficacy and safety of up to 144 weeks of bulevirtide monotherapy for chronic hepatitis delta and 96 weeks of posttreatment follow-up

Heiner Wedemeyer, Soo Aleman, Antje Blank, Pietro Andreoné et autres

13 citationsJournal of Hepatology

2025 conference-abstractOpenAlex

OS-066 Predictors of undetectable hepatitis delta virus RNA at 48 weeks after end of treatment with bulevirtide monotherapy in the MYR 301 study

Soo Aleman, Maurizia Rossana Brunetto, Antje Blank, Pietro Andreoné et autres

9 citationsJournal of Hepatology

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.